A Textbook of Clinical Pharmacology and Therapeutics
A Textbook of Clinical Pharmacology and Therapeutics
A Textbook of Clinical Pharmacology and Therapeutics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Note: Page numbers in italics refer to figures <strong>and</strong> tables.<br />
� phase 15<br />
‘ABCD’ rule, antihypertensive drugs 187<br />
abciximab 93, 209<br />
Aberdeen–Dundee intensive monitoring system<br />
65<br />
ablation therapy, cardiac dysrhythmias 222<br />
absence seizures, drugs for 134<br />
absorption <strong>of</strong> drugs 17, 18<br />
children 52, 54<br />
drug interactions 75<br />
tetracyclines 329, 389<br />
elderly patients 56<br />
eye 21, 423, 429<br />
folate 392<br />
heart failure 34<br />
iron 389<br />
kidney disease on 35<br />
nose 21<br />
oral route 19–20<br />
skin 20–1, 22, 414<br />
children 52, 54<br />
abuse <strong>of</strong> substances 433–43<br />
acamprosate 441<br />
acarbose 290<br />
accumulation <strong>of</strong> drugs 13, 14<br />
acetazolamide 274–5, 426<br />
N-acetyl-benzoquinone imine (NABQI) 27<br />
acetyl cysteine 30, 242, 260, 447<br />
acetylation 25<br />
acetylator status 80–1, 82<br />
acetylcholine receptor agonists 7<br />
acetylcholinesterase, deficiency in Alzheimer’s<br />
disease 131<br />
acetylcholinesterase inhibitors, adverse effects on<br />
lungs 243<br />
ACIC-TP (aciclovir phosphates) 345<br />
aciclovir 345–6<br />
eye 427<br />
herpes simplex in HIV infection 359<br />
skin infections 417<br />
acid secretion, stomach 247, 248<br />
acidic drugs, renal reabsorption 32<br />
acidification <strong>of</strong> urine 279<br />
acipimox 181<br />
acitretin 416<br />
acne 411–12<br />
drugs causing 418<br />
acquired immune deficiency syndrome see HIV<br />
infection<br />
acrivastine 405<br />
acromegaly 316–17<br />
activated charcoal 445, 446<br />
activated partial thromboplastin time, heparin<br />
therapy 206<br />
active immunity 399<br />
active transport<br />
distal renal tubular reabsorption 33<br />
gastrointestinal drug absorption 19–20<br />
acute bronchitis 235<br />
acute coronary syndrome 198, 199<br />
see also myocardial infarction<br />
acute intermittent porphyria 81, 84, 154<br />
adalimumab 171<br />
addiction see dependence on drugs<br />
adefovir dipivoxil 261, 349<br />
INDEX<br />
adenosine 225–6<br />
dipyridamole <strong>and</strong> 209, 226<br />
adenylyl cyclase 208<br />
β 2-adrenoceptor agonists on 236–7<br />
lithium on 121<br />
Parkinson’s syndrome 124<br />
adjuvant chemotherapy 367<br />
adjuvants (immune) 407<br />
adrenal cortex<br />
hormones 302–5<br />
see also corticosteroids<br />
suppression 302, 306, 414<br />
tetracosactide test 318<br />
adrenal medulla, hormones 305–6<br />
adrenaline 227, 305<br />
anaphylactic shock 405, 406<br />
cardiopulmonary resuscitation 221<br />
with local anaesthetics 153<br />
adrenoceptor(s)<br />
classification 7<br />
eye 424<br />
�-adrenoceptor antagonists 193<br />
on bladder 279<br />
for prostatic obstruction 280<br />
� 2-adrenoceptor agonists 150, 426<br />
�-adrenoceptor antagonists 189–90, 201<br />
for cardiac dysrhythmias 223–4<br />
eye, systemic absorption 429<br />
heart failure 190, 214<br />
hyperthyroidism 294<br />
ischaemic heart disease 198, 199, 201<br />
migraine prophylaxis 143<br />
portal hypertension 261<br />
verapamil <strong>and</strong> 191, 192, 224, 225<br />
withdrawal 10<br />
� 2-adrenoceptor agonists 236–7<br />
asthma 234<br />
chronic obstructive pulmonary disease 236<br />
adrenocorticotrophic hormone 318<br />
adsorption, on apparent volume <strong>of</strong> distribution<br />
12<br />
advanced life support 220–1<br />
adverse effects <strong>of</strong> drugs 3–4, 62–70<br />
children 54–5<br />
combinations to minimize 72<br />
cytotoxic drugs 369–71<br />
drug interactions 73–7<br />
elderly patients 56<br />
on eye 428<br />
on lungs 243<br />
on skin 417–19<br />
see also under skin<br />
afterload, cardiac 212<br />
age-related macular degeneration 428<br />
agonists 6, 7<br />
dose–response curves 6<br />
agranulocytosis 69<br />
clozapine 113<br />
AIDS see HIV infection<br />
airways obstruction, �-adrenoceptor antagonists<br />
190<br />
akathisia 112, 126<br />
albumin<br />
liver disease 37–8, 274<br />
nephrotic syndrome 273<br />
alcohol 439–42<br />
metronidazole <strong>and</strong> 330, 442<br />
pregnancy 50, 440<br />
procarbazine <strong>and</strong> 373<br />
sensitivity 80<br />
sleep <strong>and</strong> 107<br />
withdrawal, antipsychotic drugs <strong>and</strong> 115<br />
see also alcoholism<br />
alcohol dehydrogenase 25<br />
alcoholism 440–2<br />
thiamine 266<br />
aldesleukin (interleukin-2) 384, 407<br />
aldosterone 305<br />
aldosterone antagonists 193, 305<br />
heart failure 214<br />
myocardial infarction 200<br />
alefacept 415<br />
alemtuzumab 383<br />
alfentanil 150, 161<br />
alginate, reflux oesophagitis 252<br />
alkalinization <strong>of</strong> urine 279<br />
alkalosis, loop diuretics 275<br />
alkylating agents 372–3<br />
aplastic anaemia 395<br />
allergic asthma 233<br />
omalizumab for 241<br />
allergic rhinitis 405, 406<br />
allergy<br />
adverse drug reactions 63, 66–7<br />
lungs 243<br />
mediator blocking 405–6<br />
allopurinol 172–3<br />
ciclosporin <strong>and</strong> 402<br />
6-mercaptopurine <strong>and</strong> 173, 376–7<br />
allylamines 343<br />
alopecia<br />
<strong>and</strong>rogenic 412<br />
cytotoxic drugs 371<br />
drugs causing 418<br />
alprostadil<br />
cavernosal injection 315<br />
ductus arteriosus 313<br />
alteplase 199, 202<br />
alternative medicines 97–102<br />
altitude sickness, acetazolamide 274<br />
aluminium hydroxide 250<br />
Alzheimer’s disease 131–2<br />
amantadine<br />
elderly patients 58<br />
influenza 348<br />
Parkinson’s disease 126<br />
amikacin 328<br />
plasma concentrations 42<br />
amiloride 276<br />
hyperkalaemia 280<br />
�-aminobutyric acid (GABA) 133<br />
aminoglutethimide 384<br />
aminoglycosides 327–8<br />
ciclosporin <strong>and</strong> 402<br />
eye 427<br />
plasma concentration monitoring 42<br />
platinum compounds <strong>and</strong> 374<br />
renal failure 37<br />
urinary tract infections 33<br />
5-aminolevulinic acid synthetase, induction 84